Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Medicine, Hematology, Oncology +17

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Meral Beksaç, Ludmila Bezdîčková et al. · Haematologica · 2008 · 514 citations · Full text

Medicine, Hematology, Pathology +17

A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

Benedetto Bruno, Marcello Rotta, Francesca Patriarca et al. · New England Journal of Medicine · 2007 · 504 citations

Medicine, Hematology, Oncology +16

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

Medicine, Hematology, Immunology +17

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

David G. Maloney, Arthur J. Molina, Firoozeh Sahebi et al. · Blood · 2003 · 407 citations · Full text

Medicine, Oncology, Transplant Immunology +11